Content about diagnostic tests

March 7, 2014

It's finally happening. Pfizer has placed the ball at the line of scrimmage. And based on the X's and O's to come out of its Lipitor OTC actual-use study, Pfizer will be making its run with its eye on the ultimate prize — a successful Rx-to-OTC switch of a statin.

Only this time, the Food and Drug Administration may not be as quick to sack Pfizer's switch attempt. With the advances and pervasion of health technology in the self-care space by way of smartphones and tablets; with the evolution of the pharmacist as a healthcare professional able to practice at the top of their license; and with the adoption of diagnostic tests like a cholesterol panel that can be physically administered in the pharmacy, consumers may finally get it right when self-selecting a statin.

Because it's the consumer actual-use studies that have scuttled just about every statin switch attempt in the past. In the last switch of Mevacor, FDA advisory panelists determined the statin was safe enough for the self-care space. And it was effective. It's just that the consumers who would be right for an OTC statin didn't appropriately self-select. And if they can't appropriately self-select, what's the point, really?

It's finally happening. Pfizer has placed the ball at the line of scrimmage. And based on the X's and O's to come out of its Lipitor OTC actual-use study, Pfizer will be making its run with its eye on the ultimate prize — a successful Rx-to-OTC switch of a statin. 

March 7, 2014

A team of researchers from UCLA's Henry Samueli School of Engineering and Applied Science has developed a Google Glass application and a server platform that allow users of the wearable, glasses-like computer to perform instant, wireless diagnostic testing for a variety of diseases and health conditions.

LOS ANGELES — A team of researchers from UCLA's Henry Samueli School of Engineering and Applied Science has developed a Google Glass application and a server platform that allow users of the wearable, glasses-like computer to perform instant, wireless diagnostic testing for a variety of diseases and health conditions.

February 11, 2014

Joining the ranks of Hy-Vee and Meijer, HomeTown Pharmacy, which is based here in Newaygo, has announced that it is now offering free flu and strep throat testing as part of a collaborative patient care study.

NEWAYGO, Mich. — Joining the ranks of Hy-Vee and Meijer, HomeTown Pharmacy, which is based here in Newaygo, has announced that it is now offering free flu and strep throat testing as part of a collaborative patient care study.

June 24, 2013

Mylan Specialty has appointed Roger Graham as president, the Mylan subsidiary said Monday.

PITTSBURGH — Mylan Specialty has appointed Roger Graham as president, the Mylan subsidiary said Monday.

Graham previously worked for Advandx, a privately owned company that develops in-vitro diagnostic tests for infectious diseases and will report to Mylan North America president Tony Mauro. Mylan Specialty markets the EpiPen auto-injector for emergency treatment of severe allergic reactions, among other products.

May 31, 2012

Walgreens-owned clinic operator Take Care Clinics now is offering three new diagnostic tests and administrative physicals — a move that also advances the Well at Walgreens strategy to enhance services as a community healthcare provider and transform to a health and daily living destination.

CONSHOHOCKEN, Pa. — Walgreens-owned clinic operator Take Care Clinics now is offering three new diagnostic tests and administrative physicals — a move that also advances the Well at Walgreens strategy to enhance services as a community healthcare provider and transform to a health and daily living destination.

The launch of these new services is based on input from patients, managed care organizations and healthcare providers on ways to help prevent the progression of disease and use the most appropriate point of care, the company said.

November 3, 2011

The Food and Drug Administration has approved 35 new drugs over the past 12 months, the agency said Thursday.

SILVER SPRING, Md. — The Food and Drug Administration has approved 35 new drugs over the past 12 months, the agency said Thursday.

April 21, 2011

Companies that make vaccines, drugs and diagnostic tests for influenza will become key stakeholders in the World Health Organization’s Global Influenza Surveillance Network under an agreement reached at the Open Ended Working Group that WHO coordinated to support global preparedness for a future influenza pandemic.

LONDON — Companies that make vaccines, drugs and diagnostic tests for influenza will become key stakeholders in the World Health Organization’s Global Influenza Surveillance Network under an agreement reached at the Open Ended Working Group that WHO coordinated to support global preparedness for a future influenza pandemic.